Literature DB >> 23291668

Diffuse alveolar haemorrhage in ANCA-associated vasculitis.

Stephen West1, Nishkantha Arulkumaran, Phillip W Ind, Charles D Pusey.   

Abstract

Diffuse alveolar haemorrhage (DAH) is a serious complication of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). A literature review was performed to ascertain the diagnostic features, treatment, and outcome of this rare but serious condition. Haemoptysis and dyspnoea are common but non-specific features. Chest radiography is usually abnormal, and high-resolution computerised tomographic scanning is more sensitive. Increased uptake of inhaled carbon monoxide and reduced clearance of C(15)O on lung function testing is suggestive of intra-alveolar blood. Fiberoptic bronchoscopy and bronchoalveolar lavage are useful when a super-added infection is suspected. Concurrent renal disease is common and contributes to the morbidity and mortality. Treatment should be individualised, and it is based on glucocorticoid and cyclophosphamide induction with azathioprine maintenance. The role of plasmapheresis is unclear, and is currently being evaluated. Patients are at risk of disease and treatment-related long-term complications. Ongoing research into the most efficacious therapeutic regimens associated with the least side effects is especially important.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291668     DOI: 10.2169/internalmedicine.52.8863

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  18 in total

1.  A 27-year-old woman presenting with refractory hypoxaemic respiratory failure, haemoptysis and thyrotoxicosis: a rare manifestation of propylthiouracil therapy.

Authors:  Enrique O Ortiz-Diaz
Journal:  BMJ Case Rep       Date:  2014-08-22

2.  Unilateral diffuse alveolar hemorrhage in granulomatosis with polyangiitis.

Authors:  Juan Molina Collada; Gema Bonilla; Luis Gómez-Carrera; Eugenio De Miguel; Antonio Martínez Verdasco; Alejandro Balsa
Journal:  Clin Rheumatol       Date:  2019-07-23       Impact factor: 2.980

3.  Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study.

Authors:  Yan Hong; Pengxian Shi; Xia Liu; Liu Yang; Kang Li; Feng Xu; Shaoshan Liang; Zhengzhao Liu; Haitao Zhang; Yinghua Chen; Weixin Hu
Journal:  Clin Rheumatol       Date:  2019-02-08       Impact factor: 2.980

4.  Surgical lung biopsy to diagnose Behcet's vasculitis with adult respiratory distress syndrome.

Authors:  Ravikanth Vydyula; Charles Allred; Mariana Huartado; Bushra Mina
Journal:  Lung India       Date:  2014-10

Review 5.  The challenge of bleeding in antiphospholipid antibody-positive patients.

Authors:  Giulia Pazzola; Stéphane Zuily; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

Review 6.  Diffuse Alveolar Hemorrhage in Autoimmune Diseases.

Authors:  Marco Ulises Martínez-Martínez; David Alejandro Herrera-van Oostdam; Carlos Abud-Mendoza
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

7.  Deep Vein Thrombosis as a Rare Presentation in a Female With Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis.

Authors:  Wan Syamimee Wan Ghazali; Nurashikin Mohammad; Asmahan Mohd Ismail
Journal:  Arch Rheumatol       Date:  2017-01-18       Impact factor: 1.472

Review 8.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.

Authors:  Marc Hilhorst; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2015-05-08       Impact factor: 10.121

Review 9.  Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  B Lazarus; G T John; C O'Callaghan; D Ranganathan
Journal:  Indian J Nephrol       Date:  2016 Mar-Apr

Review 10.  Concurrent pulmonary hemorrhage and deep vein thrombosis in a child with ANCA-associated vasculitis: case report and review of literature.

Authors:  Shi-Ting Tseng; Min-Hua Tseng; Jing-Long Huang
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-10       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.